Acquiring Company
Sumitovant Biopharma Ltd
Acquired Company
Myovant Sciences
Description
Sumitovant Biopharma Ltd. ("Sumitovant") and Myovant Sciences Ltd. ("Myovant") announced today that Sumitovant has successfully completed its acquisition of Myovant originally announced October 23, 2022. Sumitovant has acquired all outstanding shares of Myovant not already owned by Sumitovant in an all-cash deal with a total transaction value of approximately $1.7 billion. With the completion of the acquisition, Myovant will be delisted from the New York Stock Exchange, and its shares will no longer be publicly traded.
Other recent acquisitions in Therapeutics and Pharmaceutical
Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.
- Vistagen Announces Closing Of Pherin Pharmaceuticals Acquisition (February 2, 2023)
- Shockwave Medical Completes Acquisition Of Neovasc (April 11, 2023)
- Rhythm Pharmaceuticals Announces Acquisition Of Xinvento B.V. And Portfolio Of Investigational Therapeutics (February 27, 2023)
- Kymanox Acquires Eu Based Anteris Medical And Anteris Helvetia (February 2, 2023)
- Snbl To Acquire Satsuma Pharmaceuticals (April 16, 2023)
- Chiesi Farmaceutici S.P.A. Completes Acquisition Of Amryt Pharma Plc (April 12, 2023)
Who to call at Sumitovant Biopharma Ltd, and when
When Sumitovant Biopharma Ltd changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day Sumitovant Biopharma Ltd raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Sumitovant Biopharma Ltd, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Sumitovant Biopharma Ltd. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Sumitovant Biopharma Ltd makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Frequently asked
Who acquired Myovant Sciences?
Myovant Sciences was acquired by Sumitovant Biopharma Ltd. The deal was reported on March 10, 2023. Sumitovant is a technology-driven biopharmaceutical company accelerating development and commercialization of new potential therapies for patients with rare conditions and other diseases. Sumitovant Biopharma Ltd is privately held and operates in Biotechnology.
When did Sumitovant Biopharma Ltd acquire Myovant Sciences?
Sumitovant Biopharma Ltd's acquisition of Myovant Sciences was reported on March 10, 2023. Sumitovant Biopharma Ltd. ("Sumitovant") and Myovant Sciences Ltd. ("Myovant") announced today that Sumitovant has successfully completed its acquisition of Myovant originally announced October 23, 2022. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Myovant Sciences do?
Myovant Sciences aspires to redefine care for women and men through purpose-driven science, empowering medicines, and transformative advocacy worldwide. It is privately held, operating in Biotechnology.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.